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Summary The vascularisation and perfusion of seven subcutaneously xenografted human glioma lines
established from surgical specimens has been analysed using an anti-collagen type IV antibody to visualise the
vascular walls in combination with a perfusion marker (Hoechst 33342). A computer-based digital image
processing system was employed for quantitative analysis of the parameters. The vascular architecture of
individual tumours belonging to the same tumour line showed a consistent similarity, while substantial
differences occurred between the various tumour lines derived from different patients. Despite the presence ofa
large inter-tumour variation in vascular area as a proportion of the tumour area, this vascular parameter
clearly showed tumour line-specific characteristics. The perfused fraction of the tumour vessels also showed a
large inter-tumour variation for all tumour lines ranging from 20% to 85%, but the majority of tumours ofall
lines had perfusion fractions of more than 55%. Despite large variation, the perfused vascular area as a
proportion of the tumour cross-sectional area exhibited clear tumour line-specific tendencies. These observa-
tions suggest that consistent differences in vascular parameters are present between glioma xenograft lines,
although the tumour lines all originated from histologically similar human high-grade gliomas. These differ-
ences may have important consequences for treatment and clinical behaviour of this type of tumour.
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Neovascularisation is a prerequisite for expansive growth of
solid tumours and is correlated with the potential for meta-
stasis. (Weidner et al., 1991; Folkman and Shing, 1992). It is
now well established that the vascular system of tumours is,
however, very inefficient. Great variations in regional blood
flow and intermittent perfusion of the vascular bed are
reported to be present in a variety of tumours (Trotter et al.,
1989; Farrell et al., 1991). Morphological abnormalities in
vascular structures and increased intratumoral pressure may
at least in part be responsible for these observations (Vaupel
et al., 1987; Jain, 1988, 1991). It has become clear that these
phenomena have great significance for tumour metabolism
and contribute to increased resistance to radiotherapy owing
to regional hypoxia while incomplete tissue perfusion results
in limitations in drug delivery (Vaupel et al., 1987, 1989;
Jain, 1991). Gliomas are characterised by an exceptionally
high degree of vascularisation (Brem et al., 1972; Boucher
and Jain, 1992). This high degree of vascularisation may be
related to the malignant behaviour of these tumours and
reflects.the high angiogenic potential of glioma cells. To
understand the mechanisms involved in the process of neo-
vascularisation and tumour progression and its relevance for
tumour biological behaviour and therapy response (prog-
nosis), assessment of both morphological and functional
aspects of the vascular system is necessary (Brem et al., 1972,
1990). In general, morphological aspects are analysed using
stereological principles such as the point counting method
(Chalkley, 1943) and functional information is obtained
using autoradiographic methods or by contrast fluids or
perfusion markers injected into blood vessels and thereby
delineating perfused areas (Jain, 1988; Trotter et al., 1989).
In most reports only morphological or only functional
aspects are studied. In this study we have analysed simul-
taneously the patterns of vascularisation and perfusion of
subcutaneously growing xenografts of seven different human
gliomas implanted in athymic mice. Vascular morphology
was visualised with an antibody directed against the basal
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lamina of blood vessels and tumour perfusion was visualised
with the fluorescent perfusion marker Hoechst 33342. A
computer-based digital image processing system was em-
ployed for quantitative analysis of the parameters.
Materials and methods
Tumours
Tumours used in this study were derived from seven different
primary human gliomas which were passaged 3-7 times
subcutaneously in nude mice (Balb/c nu/nu mouse). In this
study we use the terminology tumour line to indicate the
collection of tumours derived from the same primary human
tumour.
Forty tumours were investigated; from each tumour line
several passages were examined. Tumour weight ranged from
0.06 to 0.47 g. The experimental procedures were approved
by the local ethical committee for animal use.
Immunohistochemical staining andperfusion marker
Athymic mice bearing a subcutaneous human glioma in the
right flank were injected intravenously via one of the lateral
tail veins with 0.05 ml of a solution of PBS (phosphate-
buffered saline, pH 7.4) containing 15 mgkg-' of the per-
fusion marker Hoechst 33342 (Sigma, St Louis, MO, USA).
To prevent diffusion of Hoechst 33342 to adjacent non-
perfused vascular structures, mice were killed 1 min after
injection. Tumours were quickly removed and frozen and
stored in liquid nitrogen. Frozen tissue sections, 5jtm thick,
were made using a freeze microtome. Four sections were
taken from the central tumour region and four sections from
the peripheral locations. As marker of the basal lamina of
the tumour microvasculature an antibody against the basal
lamina component collagen type IV was used (rabbit poly-
clonal antibody Collagen Type IV, Euro-Diagnostics BV,
Oss, The Netherlands). This staining could be visualised in
the fluorescence microscope (Axiovert, Zeiss) using an
immunohistochemical procedure with as second antibody
goat anti-rabbit immunoglobulin (TRITC labelled, Tago,
Burlingame, CA, USA). As a first step frozen sections were
air dried and fixed in acetone for 3 min. Then they wereHuman gliomas in the athymic nude mouse
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washed in PBS for Omin. Subsequently sections were pro-
cessed at room temperature by a 45 min incubation with the
antibody collagen type IV, 10 min washing in PBS and then
a 30 min incubation followed by the second antibody. This
procedure resulted in an excellent fluorescent signal of the
vascular pattern as could be detected by the fluorescence
microscope with the 510-560 nm excitation and 590 nm
emission filter. There was a minimal background staining
which did not interfere with the interpretation of the fluores-
cent signal. In the fluorescence microscope Hoechst 33342
could be visualised in ultraviolet light showing a blue fluo-
rescence (filter with excitation at 365 nm and emission at
420 nm) in the same sections as stained with collagen type
IV. The stain Hoechst 33342 specifically labelled the nuclei of
the cells adjacent to the vessel walls, thereby delineating the
perfused vessels (Figure 1).
Whole tumour sections were scanned by a computer-
controlled procedure using a high-resolution intensified solid-
state camera for quantitative analysis. A detailed description
of this method is given by Rijken et al. (submitted). Briefly,
each tumour section was completely scanned twice with the
fluorescence microscope using the two different filters. After
processing all fields (field size 1.22mm2, 1Ox objective) of
each scan the scanned area was reconstructed from the sepa-
rate processed images into one large image. This resulted in
two composite images, one with the vascular structures (as
stained by collagen IV) and another with the perfused areas
(Hoechst).
When both composite images were combined the overlap-
ping structures represented those vascular structures which
were perfused by Hoechst at the time of injection (perfused
vascular area). The area of these overlapping structures
divided by the total vascular area yielded the perfusion frac-
tion (PF) in this section, indicating the fraction of vessel
structures that were perfused. The relative vascular area
Figure 1 Delineation of perfused blood vessels by the perfusion
marker Hoechst 33342 staining the nuclei adjacent to perfused
vessels (x 200).
(RVA) was expressed as the total surface of all vascular
structures divided by the total tumour surface. The relative
perfused tumour area (RPTA) was defined as the product of
RVA and PF, that is the perfused vascular area divided by
the tumour area.
Perfused vessel area (PF) x Total vessel area (RVA) total vessel area total tumour area
Perfused vessel area (RPTA) total tumour area
This value reflects the perfused area of vascular structures
per unit tumour area.
Histology
Haematoxylin and eosin-stained sections adjacent to the sec-
tions used for quantitative analysis of vessel structures and
perfusion were made for histological examination. Hema-
toxylin and eosin-stained sections of biopsies from the
primary tumour were also examined histologically and com-
pared with xenografts derived from these tumours.
Statistics
The means of the measurement of the four central and/or
peripheral sections for each tumour were used for further
statistical analysis.
For each tumour line the vascular parameters (RVA, PF
and RPTA) were compared between central and peripheral
regions by means of a paired Student's t test. For both
peripheral and central regions as well as for the whole
tumour, statistical comparison of PF, RVA and RPTA
between the tumour lines was done using the analysis of
covariance controlling for tumour weight. To determine
where these differences in the means of any two groups was
present, the Tukey test for multiple comparisons was applied.
A P-value below 0.05 was considered statistically
significant.
Results
Morphology ofparent human tumours andxenografts
Haematoxylin and eosin-stained sections were made for his-
tological examination. In Table I the histology of primary
tumours and xenografts is presented. The xenografts were
composed of densely packed tumour cells of medium size.
The tumour cells showed marked nuclear polymorphism. The
number of mitoses varied from 2-4 per high-power field
(E18, E49, E120) to 6-8 per high-power field (E2, E80, E98,
El10). Delicate fibrovascular septa were present in all xeno-
grafts. Dispersed small areas of necrosis were seen in tumour
lines E18, E49 and E80. Pseudo-pallisading of tumour cells
around areas of necrosis was observed in tumour line E80.
Bizarre multinucleate giant cells were present in El10. In our
study we did not find a consistent relationship between histo-
pathological characteristics and vascular parameters. More
specifically, scattered necrosis was sometimes observed in
perfused tumour regions as well as in apparently vital areas
in non-perfused tumour regions.
Vascular architecture
Tumours belonging to the same tumour line were found to
have consistently similar vascular appearances, even up to
seven passages. there were, however, clear differences in vas-
cular patterns between tumours from different tumour lines,
as shown in Figure 2. This figure demonstrates the charac-
teristic aspects of vascular architecture of the seven glioma
xenografts. It can be seen that the tumour line E2 is com-
posed of numerous very small and short vessel structures
which are homogenously distributed. Tumour lines E120 and
E18 show abundant vascular structures which are homogene-Human gliomas in the athymic nude mouse
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Table I Histology of primary human tumours and xenografts
Patient
Age Xenografts
Tumour Histology Sex (years) Mitoses Necrosis Specialfeatures
E2 AA M 33 6-8 -
E18 GBM F 46 2-4 + Cysts
E49 GBM F 48 2-4 +
E80 GBM M 70 6-8 + Cysts, PP
E98 GBM M 69 6-8 -
EllO GBM M 56 6-8 - MNG Cell
E120 GBM F 66 2-4 -
AA, anaplastic astrocytoma; GBM, glioblastoma multiforme; F, female; M, male; PP,
pseudo pallisading cells; MNG, multinucleated giant cells.
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Figure 2 Digitised images of vascular architecture of seven
glioma xenograft lines. Complete sections through the middle of
the tumour are presented for all seven tumour lines illustrating
the characteristic vascular patterns for the individual tumour
lines. All tumours belonging to the same tumour line showed
identical vascular arrangements (x 25).
ously distributed in E120. E18 shows cyst-like formations
without vessels, as does tumour line E80. In E80 vessels are
less numerous but larger and more elongated than in E120
and E18. In tumour line E98 many medium-sized tumour
vessels are homogeneously distributed throughout the
tumour. In tumour line El10 small vessels are present in the
central area and larger, more elongated, vessels in the tumour
periphery. Tumours of E49 are characterised by long stretch-
ed vessels widely separated from each other in the tumour
periphery with very few vessels in the tumour centre.
These differences in vascular architecture between the
tumour lines suggest that, although all xenografts originate
from human gliomas, tumour cells from different parent
tumours induce different vascular patterns when xenotrans-
planted in mice.
Relative vascular area
The ratio of the mean relative vascular area as determined by
the image analysis system varied from 7% to 14% for the
various tumour lines (see Table II and Figure 3a) meaning
that 7-14% of the tumour area in a section was occupied by
vascular structures. As reflected in the coefficient of variance
(CV), there was a large inter-tumour variability for RVA in
one tumour line. Within the same tumour line the mean
relative vascular area was usually lower in the central sec-
tions than in the peripheral sections. Only in the line E120
this difference is significant (P<0.05, paired Student's t-test).
Significant differences in relative vascular area could also be
demonstrated between several tumour lines. Considering the
total mean RVA, tumour lines E80, E 110 and E120 were
found to have significantly larger vascular areas than E2 and
E49 (P<0.05, Tukey test). The significant differences in
RVA for the different glioma xenografts are summarised in
Table III.
The observations on both vascular architecture and vas-
cular area indicate that characteristic differences in the degree
of vascularisation exist between the various tumour lines. No
correlation was found between tumour weight and RVA.
Perfusionfraction
As can be seen in Figure 3b the perfusion fraction showed a
large variation for all tumour lines and for both central and
peripheral regions, ranging from 20% to 85% (see cvPF in
Table II). Perfusion fractions of 20-40% were seen for only
one or two tumours or tumour regions of each tumour line;
the majority of tumours were found to have perfusion frac-
tions of 55% or higher. The mean perfusion fraction was
about 60% for all tumour groups and the median perfusion
fraction was usually considerably higher (55-75%). For indi-
vidual tumours low values for central and high values for
peripheral perfusion fraction or vice versa were observed,
although no significant differences in the mean tumour per-
fusion fraction between central and peripheral sections in
tumours belonging to one tumour line (paired Student's t-
test) or between tumours from different tumour lines could
be found (Tukey test). There was no correlation between
tumour weight and PF. As an example of characteristic
patterns in the vascular parameters RVA and PF, in Figure 4
the mean RVA and PF are shown for individual tumours
belonging to the lines E120, E80 and E49. These data clearly
show a wide range of values for individual tumours for the
two vascular parameters but a tendency towards clustering
can be seen for tumours belonging to the same tumour line.
This indicates that the majority of tumours belonging to the
same tumour line have tumour line-specific values for the
combination of RVA and PF, distinguishing these tumours
from tumours derived from other lines.
Relativeperfused tumour area
The relative perfused tumour area (RPTA) is defined as the
perfused vascular area divided by the tumour area, thus
reflecting the perfused tumour area (Table II and Figure 3).
It is clear from Figure 3c that some tumour lines show a
great variability (E18, E80, E98) in RPTA, while the varia-
tion in other tumour lines or tumour regions is limited (E49,
E120c and E120p). The mean values for all tumour lines
ranged from 0.045 to 0.085. Owing to the large variation,Humangliomas in theathymic nude mouse
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Table II Vascular parameters for seven human glioma xenograft lines
PFCV RVA RVA CV RPTA RPTA CV
Tumour PF± s.d. (%) (mean±s.d.) (%) (mean±s.d.) (%)
Whole tumour
E2 0.58±0.16 28 0.08±0.02 21 0.049±0.02 41
E18 0.63±0.18 28 0.11±0.05 48 0.075±0.06 77
E49 0.63±0.21 33 0.07±0.02 28 0.044±0.01 34
E80 0.62±0.15 24 0.13±0.04 27 0.085±0.03 38
E98 0.62±0.26 42 0.09±0.04 40 0.056±0.03 59
EllO 0.56±0.12 21 0.13±0.03 22 0.072±0.03 37
E120 0.44±0.08 18 0.14±0.02 13 0.060±0.02 38
Central vs Peripheral
E2 c 0.55±0.18 33 0.07±0.02 23 0.042±0.02 48
p 0.61±0.15 25 0.09±0.02 17 0.055±0.02 35
E18 c 0.61±0.20 33 0.09±0.05 52 0.059±0.04 75
p 0.66±0.20 30 0.12±0.08 61 0.090±0.07 77
E49 c 0.62±0.18 29 0.07±0.02 25 0.040±0.01 23
p 0.66±0.25 38 0.08±0.02 28 0.048±0.02 40
E80 c 0.60±0.16 27 0.13±0.04 28 0.079±0.03 41
p 0.65±0.16 25 0.14±0.04 30 0.091±0.03 36
E98 c 0.63±0.22 35 0.09±0.04 43 0.057±0.03 60
p 0.60±0.28 47 0.09±0.03 38 0.055±0.03 63
EllO c 0.53±0.11 21 0.11±0.02 17 0.061±0.02 28
p 0.59±0.13 22 0.14±0.04 26 0.083±0.03 38
E120 c 0.37±0.05 13 0.12±0.01 10 0.046±0.01 13
p 0.52±0.15 29 0.14±0.02 13 0.074±0.03 34
Values are expressed as means±standard deviations. Data based on 5-7 tumours perline, 4-5
complete sections per tumourlocation (peripheral orcentral). m, mean; CV, s.d./mean x 100%;
c, central; p, peripheral; PF, perfusion fraction; RVA, relative vascular area; RPTA, relative
perfused tumour area.
only the mean RPTA of E49 was significantly lower than the
mean RPTA of E80; no other significant differences between
the tumour lines for relative perfused tumour area (see Table
III) were found (Tukey test). It can be seen in Figure 3c,
however, that specific trends for tumour perfusion are pre-
sent. For example, both E49 and E120 tend to have a low
central perfused tumour area, with limited variation.
Although not significant, the perfused tumour area of E98 is
for most of these tumours lower than for tumours belonging
to E80. It is important to realise that the heterogeneity in
perfused tumour area as observed in these xenografts may
have important consequences for tumour oxygenation and
metabolism and thus explain differences in therapy re-
sponse.
Discussion
This study was designed to examine the variability in the
degree of vascularisation and the perfusion of seven glioma
xenografts of different origin. Our results suggest that consis-
tent differences in vascular parameters exist between the
glioma xenograft lines, although the primary tumours were
all high-grade human gliomas of similar histology. Tumour-
specific vascular arrangements were present as well as specific
trends for relative vascular area and perfusion fraction. As
the vascular system is derived from the host animal, and as
host animals and implantation site were the same for all
tumour lines, the differences in vascular parameters must at
least in part reflect differences in angiogenic properties of
glioma cells derived from different primary human tumours.
Thus, our observations underline the fact that the host tissue
surrounding the tumour is not the only determining factor of
the tumour vascular pattern. Several vascular parameters will
be discussed separately below.
Relative vascular area/vascular architecture
Characteristic differences in mean relative vascular area and
vascular architecture were noticed for the tumour lines
originating from different primary tumours, although large
intra-and inter-tumour variations were present. Certain
tumour lines were found to have a significantly higher degree
of vascularisation than others. Some tumour lines showed a
more homogeneous distribution of vessels, whereas others
were characterised by a heterogeneous vascularisation, while
individual vessel structures were also found to show tumour
line-dependent appearances. These results at in agreement
with the reports of Solesvik et al. (1982) aid Kraus et al.
(1983). Using stereological techniques Solesvik et al. (1982)
demonstrated that in human melanoma xenografts growing
subcutaneously in the nude mouse vascular parameters also
show tumour line-specific characteristics. In their study the
surface of tumour vessel structures filled with contrast
medium, vessel diameter and total vessel length and vessel
volume per unit histologically non-necrotic tumour volume
varied significantly among the five different human
melanoma lines. Kraus et al. (1983) described consistently
different vascular patterns in microangiograms of tumours of
ten different human tumour types implanted subcutaneously
in the nude mouse. In animal tumours similar characteristic
vascular patterns were found (Margualis et al., 1961; Milne
et al., 1969). In contrast, no characteristic vascular density or
vascular architecture of several human tumours (melanoma,
six different sarcomas) transplanted subcutaneously in nude
mice, as shown by India ink perfusion, could be found by
Steinberg et al. (1990, 1991). In their study they found a very
high degree of heterogeneity in tumour vessel distribution as
well as great interindividual variation in tumour vessel dis-
tribution between tumours of the same tumour type.
Differences in the techniques used to visualise and quantify
tumour vessels can explain these differences in observations
on tumour vascular structures. It is also possible that some
tumour types are capable of developing a more characteristic
vascular distribution than other types.
The differences in extent ofvascularisation of tumours may
well be associated with the capacity of the tumour cells to
produce angiogenic growth factors such as basic fibroblast
growth factor (bFGF) and vascular endothelial growth factor
(VEGF). Indeed, recently Abe et al. (1993) reported
differences in bFGF mRNA levels in various glioma cell lines
and related these to a differential capacity to induce tube
formation in vitro and develop capillary networks in mice
when injected subcutaneously. Low mRNA levels in the
tumour cells were associated with poorly vascularised
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Figure 3 (a) Relative vascular area for central and peripheral
sections of seven glioma xenograft lines. (b) Perfusion fraction for
central and peripheral sections of seven glioma xenograft lines.
(c) Relative perfused tumour area for central and peripheral
sections of seven glioma xenograft lines. Each open circle
represents the mean value of the four (peripheral or central)
complete sections per tumour. The filled circles represent the
mean of each group, the horizontal bars represent the median.
The box indicates the mean ± I s.d. Abbreviations: PF, perfusion
fraction (perfused vessel area/total vessel area); RPTA, relative
perfused tumour area (perfused vessel area/total tumour area);
RVA, relative vascular area (total vessel area/total tumour area;
c, central; p, peripheral; s.d. standard deviation.
tumours in the mice. Variations in angiogenic capacity may
also be responsible for differences in vascular area and archi-
tecture seen in our tumour lines. It should be noted that,
besides the angiogenic capacity of tumour cells, the degree of
vascularisation and architecture of the vascular network are
also influenced by a number of other factors, including the
interstitial pressure of the tumour, growth stage and site of
tumour growth (Schulz-Hector et al., 1991; Hilario et al.,
1992).
It has been noted that central tumour areas may have a
poorer vascular system (and blood supply) due to central
necrosis and rarefaction of the blood vessels (Vaupel et al.,
1989). In human tumours peripheral areas have also been
shown to have a higher vascular density (Steinberg et al.,
1991). Grunt et al. (1986) performed a detailed vascular
corrosion study of Lewis lung carcinoma growing subcuta-
0 0.;05 0.1 0.15
Relative vascular area
Figure 4 Mean perfusion fraction and mean relative vascular
area of individual tumours belonging to three human glioma
xenograft lines (A, E49; 0, E80; *, E120) illustrating the char-
acteristic patterns for each of the lines (bars = s.d.).
TableIm Statistical significance ofdifferences in vascular parameters
for seven human glioma xenograft lines
RVA PF RPTA
Mean (E120, El10, E80)>(E49, E2) NS E80>E49
(E120, E80)>E98
Central (E120, E80)>E49 NS NS
Peripheral NS NS NS
Tukey test, P<0.05. Data are derived from Table II. PF, perfusion
fraction; RVA, relative vascular area; RPTA, relativeperfused tumour
area; NS, not significant.
neously in mice and found central avascular cavities in larger
tumours. In our series we also found a tendency for the mean
vascular area to be smaller in central areas than in peripheral
regions. These differences were not very pronounced how-
ever. It is possible that different tumour types and variations
in tumour size (our tumours being relatively small) can ex-
plain these differences.
Perfusionfraction/relative perfused tumourfraction
In our study the perfusion fraction of the vascular structures
ranged from 20% to 85%. In most tumour lines only one or
two tumours or tumour regions were found to have a low
perfusion fraction (20-40%); the majority of tumours were
shown to have perfusion fractions higher than 60%. There
was, however, a large inter-tumour variation, and tumour
line specific perfusion fractions were not observed. More
specific trends were seen for the relative perfused tumour
area in several tumour lines. This can be explained by the
fact that, although the percentage of the perfused vessels may
be in the same range for many tumour lines, differences in
vascular area (and architecture) result in differences of per-
fused tumour area. Lyng et al. (1992) also assumed in their
study of six subcutaneously implanted human melanoma
lines in nude mice that differences in blood supply per viable
tumour cell were related to differences in vascular architec-
ture. The blood supply in their study was measured by
uptake of 86Rb and clearance of 33Xe.
Our results on tumour perfusion indicate that the number
of vessels per unit area is not the only determining factor for
tissue perfusion as many vessels may not be functional. It is
not clear what proportion of the non-perfused vessel areas is
permanently or temporarily non-functional. The fact that
20-85% of the vascular structures are not perfused at a
given time suggests that extensive areas of the tumours are
hypoxic or not accessible by therapeutic agents, resulting in
decreased therapeutic conditions. Even if only some of these
vessels can be reperfused, this would then imply that access
of therapeutic agents could be improved or tumour oxygena-
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tion increased, resulting in improved sensitivity to radio-
therapy.
The link between the vascular parameters of the xenografts
and their parent tumours in our study is difficult to establish
since the available tumour biopsies in most cases constitute
too small a part of the tumour to be representative. Lauk et
al. (1989) compared morphometric data of the vascular net-
work in human squamous cell carcinomas and their xeno-
transplants in nude mice (subcutaneous) and concluded that
the spatial distribution ofproliferating tumour cells as well as
differentiation characteristics appear to be retained in xeno-
graft tumours although the density of the vascular system
appeared to be host specific. It was found that distances
between tumours cells and blood vessels in original tumours
were significantly longer than in xenotransplants. This im-
plies that observations in tumour models, especially concern-
ing vascular systems, have to be interpreted carefully with
regard to the clinical relevance, although good agreements do
exist.
The combination of the use of a fluorescent perfusion
marker (Hoechst 33342) and a basal lamina membrane
marker (collagen type IV), as shown in this study, offers an
excellent opportunity to analyse and grade angiogenesis and
vascularity and to obtain information about the functional
status of the vessels of human gliomas xenografted in the
nude mouse. Regional distribution of vessel structures and
vascular architecture can be analysed very efficiently using a
computer-based digital image processing system. This system
offers the opportunity to quantify vascular profiles in whole
tumour sections or to analyse regional differences. By com-
paring the total vascular area with Hoechst-stained areas, the
perfused vascular area can be determined. In this way both
structural and functional information can be obtained from
the tumour vascular system. It is our expectation that a more
detailed analysis of individual vessel structures and inter-
capillary distance will further extend our knowledge of the
vascularisation and perfusion of the xenografts and its con-
sequences for treatment and clinical behaviour, and studies in
this direction are in preparation.
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